QuidelOrtho Corporation
NASDAQ:QDEL
40.27 (USD) • At close January 15, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | QuidelOrtho Corporation |
Symbool | QDEL |
Munteenheid | USD |
Prijs | 40.27 |
Beurswaarde | 2,708,427,309 |
Dividendpercentage | 0% |
52-weken bereik | 29.74 - 73.45 |
Industrie | Medical Instruments & Supplies |
Sector | Healthcare |
CEO | Mr. Douglas C. Bryant |
Website | https://www.quidelortho.com |
An error occurred while fetching data.
Over QuidelOrtho Corporation
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)